Changes in the use of psychotropic drugs during the course of Alzheimer’s disease: A large-scale longitudinal study of French medical records

Sep-21

AUTHORS : Dr Manon Ansart (Details for study: Aramis Lab, Institut du Cerveau et de la Moelle épinière, Hôpital Pitié Salpêtrière) now works at Université Bourgogne Franche-Comté, LEAD CNRS UMR5022, Institut Marey – I3M, 64 rue de Sully, 21000 Dijon, France – Email: marion.ansart@gmail.com / Manon.Ansart@u-bourgogne.fr – Profile: https://www.manon-ansart.fr/ AND http://leadserv.u-bourgogne.fr/en/members/manon-ansart

JOURNAL : Alzheimer’s & Dementia

REFERENCE: 7(1):e12210

DOI : 10.1002/trc2.12210

Changes in the use of psychotropic drugs during the course of Alzheimer’s disease: A large-scale longitudinal study of French medical records

More publications

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Prodromal Parkinson’s disease and subsequent risk of Parkinson’s disease and mortality

Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study